Zai Lab Limited ADR’s recently made public that its insider Amado Rafael unloaded Company’s shares for reported $0.19 million on Dec 31 ’25. In the deal valued at $17.43 per share,10,787 shares were sold. As a result of this transaction, Amado Rafael now holds 52,391 shares worth roughly $0.96 million.
Then, Amado Rafael bought 10,787 shares, generating $188,034 in total proceeds.
Before that, Edmondson Frazor Titus III sold 8,651 shares. Zai Lab Limited ADR shares valued at $148,278 were divested by the Chief Legal Officer at a price of $17.14 per share. As a result of the transaction, Edmondson Frazor Titus III now holds 19,086 shares, worth roughly $0.35 million.
A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early March with a ‘”a Sector outperform”‘ rating. BofA Securities also remained covering ZLAB and has decreased its forecast on March 03, 2025 with a “Neutral” recommendation from previously “Buy” rating. Morgan Stanley started covering the stock on December 14, 2023. It rated ZLAB as “an Overweight”.
Price Performance Review of ZLAB
On Monday, Zai Lab Limited ADR [NASDAQ:ZLAB] saw its stock fall -0.86% to $18.39. Over the last five days, the stock has gained 1.66%. Zai Lab Limited ADR shares have fallen nearly -24.32% since the year began. Nevertheless, the stocks have risen 4.25% over the past one year.
How much short interest is there in Zai Lab Limited ADR?
A steep rise in short interest was recorded in Zai Lab Limited ADR stocks on 2025-12-31, dropping by -0.79 million shares to a total of 4.25 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 5.04 million shares. There was a decline of -18.57%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 10, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $70 price target.
